Application of a new statistical approach to evaluate a clinical trial with panic disorder patients

Citation
B. Bandelow et al., Application of a new statistical approach to evaluate a clinical trial with panic disorder patients, EUR ARCH PS, 249(1), 1999, pp. 21-27
Citations number
21
Categorie Soggetti
Clinical Psycology & Psychiatry","Neurosciences & Behavoir
Journal title
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
ISSN journal
09401334 → ACNP
Volume
249
Issue
1
Year of publication
1999
Pages
21 - 27
Database
ISI
SICI code
0940-1334(199902)249:1<21:AOANSA>2.0.ZU;2-8
Abstract
In clinical trials in psychiatry, changes in severity are usually measured with ordinal level scales which are applied repeatedly during the trial, sh owing a constant decline in psychopathology scores as treatment leads to im provement. Previous non-parametric tests for repeated measures in factorial designs did not test the hypothesis that scale scores decrease constantly during the trial. A recently developed "rank test for ordered alternatives in a mixed model" was developed and applied to the data of a clinical trial in panic disorder. Thirty-seven outpatients with panic disorder and agorap hobia (PDA) were treated with imipramine (75-150 mg/day) in an 8-week open, prospective trial. Patients with intercurrent agoraphobia were instructed in practising self-exposure in their agoraphobic situations. The total scor e on the Panic and Agoraphobia Scale, the Hamilton Anxiety Scale (HAMA) and the Clinical Global Impression Scale (CGI) were used as the main efficacy measures. The new rank test showed significant treatment results in all sca les applied. Treatment results were excellent, as was shown by a decrease i n the average Panic and Agoraphobia Scale severity scores from 28.9 (range 14-45) to 13.3 (range 0-37; rank statistic T-n = 6.7; p < 0.0001). The larg est effect size r(w) of all clinician-rated scales was seen with the observ er-rated version of the Panic and Agoraphobia Scale, although closely follo wed by the CGI and the MAMA. Among the self-rated scales, the Panic and Ago raphobia Scale also showed the largest effect size. All five subscores of t he Panic and Agoraphobia Scale showed significant improvements. The highest treatment effect sizes were seen in the "panic attacks" subscore, followed by the "anticipatory anxiety" subscore. The new statistical test applied i n this study, which has some advantages in comparison with previously appli ed tests, is suitable for psychiatric treatment evaluations since it can al so be applied in the case of discrete repeated measurements.